3DT Holdings is a biomedical incubator and accelerator specializing in the development of minimally invasive medical devices for the treatment of cardiovascular and metabolic diseases and disorders. Having built a highly-integrated organization with early research and prototyping, market research, product design, manufacturing transfer, pre-clinical testing, clinical trial design, data analysis and business development, the firm is structured to develop technologies focused on a compelling clinical need, ease of use for the physician and alignment with existing clinical workflow.
